Is Wellbutrin (bupropion) a suitable treatment option for a patient with post-traumatic stress disorder (PTSD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bupropion for PTSD

Bupropion is not recommended as a treatment for PTSD itself, as it lacks evidence for reducing core PTSD symptoms, though it may be considered when PTSD co-occurs with major depressive disorder after addressing PTSD with appropriate first-line treatments. 1

Why Bupropion Is Not First-Line for PTSD

  • Major clinical guidelines do not recommend bupropion for PTSD treatment. The American Psychiatric Association and International Society for Traumatic Stress Studies identify SSRIs (fluoxetine, paroxetine, sertraline) and venlafaxine as the evidence-based pharmacotherapy options, with no mention of bupropion as an effective agent for PTSD symptoms. 1

  • The highest quality placebo-controlled trial showed no benefit. A 2007 randomized controlled trial of bupropion SR versus placebo in 30 patients with chronic PTSD found no significant difference between groups in reducing PTSD symptoms, with both groups showing similar modest improvements. 2

  • An earlier open-label study confirmed limited PTSD-specific efficacy. In 17 combat veterans treated with bupropion for 6 weeks, there was no significant change in intrusion, avoidance, or total PTSD symptom scores, though depressive symptoms and hyperarousal improved modestly. 3

  • Meta-analytic evidence supports SSRIs, not bupropion. A 2015 systematic review of 51 randomized controlled trials found small but statistically significant efficacy for fluoxetine, paroxetine, and venlafaxine in PTSD, while bupropion was not identified among effective agents. 4

When Bupropion May Have a Role

  • Consider bupropion specifically for comorbid major depressive disorder. The American College of Physicians recommends using bupropion for depression management when PTSD co-occurs with MDD, but only after addressing PTSD with appropriate first-line treatments (trauma-focused psychotherapy or SSRIs/venlafaxine). 1

  • Bupropion offers advantages when sexual dysfunction limits SSRI use. It is associated with lower rates of sexual adverse events compared to fluoxetine and sertraline, making it preferable when sexual dysfunction becomes a limiting factor with first-line SSRI treatment. 1

  • Emerging evidence suggests potential benefit in PTSD with comorbid methamphetamine use disorder. A 2025 case series of 4 patients with both PTSD and methamphetamine use disorder showed greater reduction in PTSD symptom severity (PTSD checklist scores dropping from 77 to 29) and lower relapse rates (25% vs 48.8%) compared to serotonergic agents alone, though this requires confirmation in controlled trials. 5

The Evidence-Based Treatment Algorithm for PTSD

First-line approach:

  • Trauma-focused psychotherapy is the primary intervention. The VA/DoD 2023 guideline strongly recommends Prolonged Exposure, Cognitive Processing Therapy, or EMDR, with 40-87% of patients no longer meeting PTSD criteria after 9-15 sessions. 6

When pharmacotherapy is needed:

  • Use SSRIs or venlafaxine as first-line medications. Paroxetine, sertraline, and venlafaxine are the three medications with strongest evidence, showing consistent positive results across multiple placebo-controlled trials. 6

  • Continue medication for 6-12 months minimum after symptom remission. Discontinuation leads to high relapse rates of 26-52% when shifted to placebo compared to only 5-16% maintained on medication. 6

Critical Pitfall to Avoid

  • Do not use bupropion as monotherapy expecting PTSD symptom reduction. The placebo-controlled trial evidence clearly demonstrates it does not reduce core PTSD symptoms (intrusion, avoidance, hyperarousal) beyond placebo effects. 2 If depression is the primary target in a patient with comorbid PTSD and MDD, bupropion can be used, but the PTSD itself requires trauma-focused psychotherapy or SSRI/venlafaxine treatment. 1

References

Guideline

Bupropion in PTSD Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis.

The British journal of psychiatry : the journal of mental science, 2015

Guideline

Treatment of Post-Traumatic Stress Disorder (PTSD)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

In a patient with PTSD who is taking escitalopram 20 mg and has persistent worry and self‑doubt, would adding bupropion be helpful?
What is the optimal medication plan for a patient taking bupropion extended‑release 300 mg and escitalopram 20 mg who has a history of methamphetamine use, post‑traumatic stress disorder, and sleep disturbances?
What is the recommended treatment strategy for a patient with depression and post‑traumatic stress disorder who is taking venlafaxine, cariprazine (Vraylar), and bupropion (Wellbutrin)?
In a patient with bipolar II disorder, comorbid depression and post‑traumatic stress disorder who is taking aripiprazole (Abilify) 5 mg and bupropion (Wellbutrin) 150 mg but remains very depressed, should the bupropion be discontinued and the aripiprazole dose increased?
Does venlafaxine (Effexor) work for post‑traumatic stress disorder (PTSD)?
How long will it take for vitamin B12 (cobalamin) supplementation to start alleviating symptoms in an adult patient with a possible functional B12 deficiency and neurological symptoms?
What is the treatment for an adult with 11 beta-hydroxylase deficiency?
Can Seroquel (quetiapine) cause restlessness, particularly in the form of akathisia, in patients?
What is the best course of treatment for a patient with a black tongue and acid reflux, considering their age, medical history, and lifestyle habits?
What is the difference between glucocorticoid and mineralocorticoid in a patient with Addison's disease presenting with hypotension?
What is the recommended dosing regimen for pantoloc (pantoprazole) twice daily (bid) for a patient with an ulcer?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.